RXO Form 4: 20,308-share buy at $12.37; 49,542 to GRAT
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
RXO, Inc. — Form 4 insider transaction
A company director reported transactions on November 7, 2025. The filing shows a purchase of 20,308 shares of common stock at $12.37 per share, held indirectly by a trust. The director also reported transfers coded “G” for no consideration, moving 36,508 shares from the trust and 13,034 shares from direct ownership.
Per the explanation, the director transferred an aggregate of 49,542 shares to a grantor retained annuity trust (GRAT), where the director is trustee and sole beneficiary. Following these transactions, 49,542 shares were listed as indirectly owned by the GRAT.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 20,308 shares ($251,210)
Net Buy
4 txns
Insider
Szlosek Thomas A
Role
Director
Bought
20,308 shs ($251K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 20,308 | $12.37 | $251K |
| Gift | Common Stock | 36,508 | $0.00 | -- |
| Gift | Common Stock | 13,034 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 36,508 shares (Indirect, By Trust);
Common Stock — 0 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What did RXO (RXO) disclose on this Form 4?
A director purchased 20,308 shares at $12.37 and transferred an aggregate of 49,542 shares to a GRAT on November 7, 2025.
What is the director’s post-transaction RXO ownership?
Post-transaction, 49,542 shares are listed as indirectly owned by the GRAT.
Were any of the RXO transfers made for consideration?
No. The filing shows code G transactions and states the transfers were for no consideration.
What roles does the director have in the GRAT?
According to the filing, the director is the trustee and the sole beneficiary of the GRAT.